thirty patients from a private practice were enrolled in an investigation designed to compare the efficacy and safety of a new nonsteroidal anti-inflammatory drug , etodolac , with those of aspirin and placebo in ameliorating pain , inflammation , and functional deficits associated with degenerative joint disease .
C0059865
etodolac
C0029408
degenerative joint